Clozapine for treatment-resistant schizophrenia: National Institute of Clinical Excellence (NICE) guidance in the real world

Clinical Schizophrenia and Related Psychoses

Volumn 4, Issue 1, 2010, Pages 49-55

  Mortimer, Ann M ^a   Singh, Praveen ^a   Shepherd, Charles J ^a   Puthiryackal, Junais ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

Author keywords

Clozapine; NICE; Psychosis; Treatment resistance

Indexed keywords

BUTYROPHENONE; CHLORPROMAZINE; CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; PHENOTHIAZINE; THIOXANTHENE;

ADULT; AGED; ARTICLE; CHRONIC STRESS; DEPRESSION; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; PATIENT COMPLIANCE; POSITIVE SYNDROME; PRACTICE GUIDELINE; PSYCHOSIS; SCHIZOPHRENIA; SUBSTANCE ABUSE; SUICIDE; THERAPY RESISTANCE; TREATMENT INDICATION; UNITED KINGDOM;

ADULT; AGED; ANTIPSYCHOTIC AGENTS; CLOZAPINE; COMORBIDITY; DRUG RESISTANCE; ENGLAND; EVIDENCE-BASED MEDICINE; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; QUALITY ASSURANCE, HEALTH CARE; RECURRENCE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; STATE MEDICINE; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 77950566143     PISSN: 19351232     EISSN: None     Source Type: Journal    
DOI: 10.3371/CSRP.4.1.4     Document Type: Article

References (18)

1. Kane J, Honigfeld G, Singer J, Meltzer H. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988;45(9):780-796.
2. McEvoy JP, Lieberman JA, Stroup TS, Davis SM, Meltzer HY, Rosenheck RA; CATIE Investigators. Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. Am J Psychiatry 2006;163(4):600-610.
3. Jones PB, Barnes TR, Davies L, Dunn G, Lloyd H, Hayhurst KP, et al. Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). Arch Gen Psychiatry 2006;63(10):1079-1087. (Pubitemid 44498387)
4. The Joint Formulary Committee. The British National Formulary. 57th edition. London: Pharmaceutical Press; 2009.
5. Davis JM. Recent developments in the drug treatment of schizophrenia. Am J Psychiatry 1976;133(2):208-214.
6. Wahlbeck K, Cheine M, Essali MA. Clozapine versus typical neuroleptic medication for schizophrenia. Cochrane Database Syst Rev 2000;(2):CD000059.
7. Leppig M, Bosch B, Naber D, Hippius H. Clozapine in the treatment of 121 out-patients. Psychopharmacology (Berl) 1989;99 Suppl:S77-79.
8. Barnett D. Guidance on the use of newer (atypical) antipsychotic drugs for the treatment of schizophrenia. NICE technology appraisal guidance 43. London: National Institute for Clinical Excellence; 2002.
9. Buchanan RW. Clozapine: efficacy and safety. Schizophr Bull 1995;21(4):579-591.
10. Lieberman JA, Phillips M, Gu H, Stroup S, Zhang P, Kong L. Atypical and conventional antipsychotic drugs in treatment-naive first-episode schizophrenia: a 52-week randomized trial of clozapine vs chlorpromazine. Neuropsychopharmacology 2003;28(5):995-1003.
11. Mortimer AM. Optimising drug treatments in rehabilitation practice. Progress in Neurology and Psychiatry 2007;11(9):6-10.
12. Mortimer AM. Estrogen and schizophrenia. Expert Reviews in Neurothererapeutics 2007;7(1):45-55.
13. Taylor DM, Smith L. Augmentation of clozapine with a second antipsychotic - a meta-analysis of randomized, placebo-controlled studies. Acta Psychiatr Scand 2009;119(6):419-425.
14. Andreasen NC, Carpenter WT Jr, Kane JM, Lasser RA, Marder SR, Weinberger DR. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry 2005;162(3):441-449. (Pubitemid 40343909)
15. Lewis S, Lieberman J. CATIE and CUtLASS: can we handle the truth? Br J Psychiatry 2008;192(3):161-163.
16. Leucht S, Corves C, Arbter D, Engel RR, Li C, Davis JM. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet 2009;373(9657):31-41.
17. McGorry PD, Killackey E, Yung A. Early intervention in psychosis: concepts, evidence and future directions. World Psychiatry 2008;7(3):148-156.
18. Ricciardi A, McAllister V, Dazzan P. Is early intervention in psychosis effective? Epidemiol Psichiatr Soc 2008;17(3):227-235.